[1]
HADKE, A., PETHE, A., VAIDYA, S. and DEWANI, S. 2022. FORMULATION DEVELOPMENT AND CHARACTERIZATION OF LYOPHILIZED FEBUXOSTAT NANOSUSPENSION. International Journal of Applied Pharmaceutics. 14, 6 (Nov. 2022), 91–99. DOI:https://doi.org/10.22159/ijap.2022v14i6.45614.